MAFA
ABBV icon

MJT & Associates Financial Advisory’s AbbVie ABBV Stock Holding History

MJT & Associates Financial Advisory’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$24.7K Buy
98
+16
+20% +$3.44K 0.02% 114
2026
Q1 		$17.8K Hold
82
– – 0.01% 127
2025
Q4 		$18.7K Hold
82
– – 0.01% 131
2025
Q3 		$19K Buy
82
+37
+82% +$7.54K 0.02% 128
2025
Q2 		$8.35K Hold
45
– – 0.01% 229
2025
Q1 		$9.43K Buy
+45
New +$8.75K 0.01% 214

Other funds holding ABBV

LMFP
Larry Mathis Financial Planning Phoenix, Arizona $124B AUM
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
ATO
Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
HCM
Hamlin Capital Management New York $4.45B AUM 22.95% 1-Year Est. Return
AAMU
AEGON Asset Management (UK) Edinburgh, United Kingdom $9.38B AUM 48.94% 1-Year Est. Return
FWCM
Ferguson Wellman Capital Management Portland, Oregon $8.19B AUM 30.56% 1-Year Est. Return

MJT & Associates Financial Advisory's ABBV Position: Q2 2026 in Review

MJT & Associates Financial Advisory increased its AbbVie (ABBV) stake by 20% in Q2 2026, buying an estimated $3.44K and bringing the position to 98 shares worth $24.7K. The position accounts for 0.02% of the portfolio, ranked #114.

MJT & Associates Financial Advisory first reported a position in ABBV in Q1 2025 and has held it in 6 quarters since. 1,432 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • MJT & Associates Financial Advisory held 98 shares of AbbVie worth $24.7K as of Q2 2026.
  • MJT & Associates Financial Advisory bought 16 AbbVie shares in Q2 2026, an estimated $3.44K.
  • AbbVie made up 0.02% of MJT & Associates Financial Advisory's portfolio in Q2 2026, its #114 holding.
  • MJT & Associates Financial Advisory first reported a position in AbbVie in Q1 2025 and has held it in 6 quarters since.
  • 1,432 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on MJT & Associates Financial Advisory's 13F filing for Q2 2026, filed 6 Jul 2026.